Pluto Bio

Every result should count toward the case. In Pluto, analyses can be saved as evidence and connected to the scientific questions they support. So when the program is reviewed, the case is already there: current, inspectable, and defensible.

The scientific case behind a program should not be rebuilt before every review. Pluto keeps analyses, evidence, comments and decisions connected as the work develops. So teams can see where the case stands, what has changed, and what still needs to be answered.

Most translational teams have the science. What they do not have is one place where it connects. Pluto structures the evidence behind every program around core scientific questions, so teams can see where the case stands as work develops.

The science behind your drug program already exists. The problem is that it lives across analyses, slide decks, lab notebooks, and people's heads. Pluto makes the biological case visible by organising every analysis and piece of evidence around the questions your program needs to answer. That gives teams a scientific case that stays current, accessible, and defensible.

Your team generates more multi-omics data than ever. The bottleneck is turning scattered evidence into a scientific case that can be inspected, defended, and kept current. When the same questions come up in every program review, every answer should not require another meeting. Pluto gives every program a shared structure for connecting evidence to the scientific case.

Every translational program is judged against the same hard questions. Is the target relevant? Does the model reflect human disease? Does the mechanism do what we expect? What evidence supports the case? Pluto makes that checklist visible, structured, and current, so teams can see the state of the science behind a program.